Hypoxia impairs the efficacy of stem cell-derived islet cell therapy, making it a potential barrier for treatment of type 1 diabetes. Wang et al. identify EDN3 as a key factor that preserves β cell identity and function in hypoxia, offering possible strategies to improve therapeutic outcomes.
- Xi Wang
- Shlomi Brielle
- Douglas A. Melton